EMC-AANL-DOX

Overview

EMC-AANL-DOX is a legumain-activated prodrug conjugate of Doxorubicin (DOX) ( HY-15142A ). EMC-AANL-DOX shows antitumor activity in mouse models of neuroblastoma (NB), breast cancer (4T1), fibrosarcoma (HT1080), and colorectal cancer liver metastases (CT26). EMC-AANL-DOX can be used for cancer research.

Application

Products | Products > Disease Areas > Cancer | Products > Disease Areas > Digestive System Disease | Products > Disease Areas > Breast Cancer | Products > Disease Areas > Liver Cancer | Products > Disease Areas > Digestive System Cancer | Products > Signaling Pathways > Others | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Research Areas > Cancer | Products > Signaling Pathways > Drug Derivative

Product Information

• Catalog No.: HY-176869
• CAS No.: 1431625-66-9
• Molecular Formula: C53H67N7O19
• Molecular Weight: 1106.13
• Purity: 99.98%
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.

Source

Original product source